Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Association Between Neovascular Age–Related Macular Degeneration and Incident Myocardial Infarction (MI)

I.U. Scott; J. Mo; R. Klein; M. Patel; Y. Duan; K. Huang; D. Liao

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2196. doi:

ARVO Annual Meeting Abstract May 2006

Intravitreal Bevacizumab for Macular Edema Associated with Hemiretinal and Central Retinal Vein Occlusion

C.A. Cordeiro; R.A. Costa; R. Jorge; D. Calucci; J. Cardillo; I.U. Scott

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4257. doi:

ARVO Annual Meeting Abstract May 2006

OCT

K.D. Rosenberg; H.W. Flynn, Jr.; I.U. Scott; A.A. Moshfeghi

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5275. doi:

ARVO Annual Meeting Abstract May 2006

Endophthalmitis Caused by Bacillus

J.J. Miller; H.W. Flynn, Jr.; W.E. Smiddy; T.G. Murray; I.U. Scott; D. Miller

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5279. doi:

ARVO Annual Meeting Abstract May 2006

Acute–Onset Endophthalmitis Following Cataract Surgery in a University Teaching Hospital (2000–2005)

H.W. Flynn, Jr.; J.J. Miller; I.U. Scott; W.E. Smiddy; T.G. Murray; D. Miller

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5293. doi:

ARVO Annual Meeting Abstract May 2005

Endophthalmitis Caused by Staphylococcus epidermidis: Clinical Outcomes and in vitro Antibiotic Susceptibilities

D.M. Miller; H.W. Flynn; D. Miller; I.U. Scott; W.E. Smiddy; T.G. Murray; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3295. doi:

ARVO Annual Meeting Abstract May 2005

Surgical Management of Macular Retinoschisis Associated With High Myopia

I.U. Scott; H.W. Flynn, Jr

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5447. doi:

ARVO Annual Meeting Abstract May 2005

Retained Lens Fragment in the New Millenium

P. Gallogly; J. Moore; I.U. Scott; H.W. Flynn; Jr; W.E. Smiddy; T.G. Murray; W. Feuer

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5511. doi:

ARVO Annual Meeting Abstract May 2005

Acute–onset Endophthalmitis Following Cataract Surgery (2000–2004): Incidence, Risk Factors, and Outcomes

J.J. Miller; H.W. Flynn, Jr; I.U. Scott; W.E. Smiddy

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5550. doi:

ARVO Annual Meeting Abstract May 2005

Delayed–onset Bleb–Associated Endophthalmitis: Clinical Features and Visual Acuity Outcomes

C.D. Quinn; H.F. Flynn, Jr; S.J. Gedde; D.L. Budenz; I.U. Scott; P.F. Palmberg; W.E. Smiddy; T.G. Murray; R.K. Parrish, II; F.E. Fantes

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5552. doi:

ARVO Annual Meeting Abstract May 2005

Non–infectious Pseudohypopyon Following Intravitreal Triamcinolone Acetonide (IVTA) Injection

H.W. Flynn; A.A. Moshfeghi; J.L. Davis; J.W. Kitchens; T.G. Murray; C.A. Puliafito; P.J. Rosenfeld; I.U. Scott; W.E. Smiddy

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):486. doi:

ARVO Annual Meeting Abstract May 2004

In Vitro Efficacy of Fluoroquinolones for Coagulase–Negative Staphylococcal Endophthalmitis Isolates

K.D. Rosenberg; H.W. Flynn Jr; I.U. Scott; P.M. Flynn; D. Miller

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):509. doi:

ARVO Annual Meeting Abstract May 2004

Current experience using blood culture bottles to identify causative organisms of endophthalmitis

J.W. Kitchens; P.M. Flynn; J. Diniz; I.U. Scott; H.W. Flynn; Jr; D. Miller

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):518. doi:

ARVO Annual Meeting Abstract May 2004

Acute–onset endophthalmitis following cataract surgery in the new millennium: incidence and visual acuity outcomes following treatment

J.J. Miller; I.U. Scott; H.W. Flynn; Jr; J. Newton

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):520. doi:

ARVO Annual Meeting Abstract May 2004

Acute–onset endophthalmitis following cataract surgery: Association between time of diagnosis, causative organism, and final visual acuity outcome.

C.D. Quinn; H.W. Flynn; I.U. Scott; W.E. Smiddy

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):522. doi:

ARVO Annual Meeting Abstract May 2004

Pseudohypopyon Following Intravitreal Triamcinolone Acetonide Injection for Cystoid Macular Edema

H.W. Flynn; Jr; A.A. Moshfeghi; I.U. Scott; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1046. doi:

ARVO Annual Meeting Abstract May 2004

Visual Acuity and Optical Coherence Tomographic Outcomes Following Intravitreal Triamcinolone Acetonide Injection for Macular Edema Associated with Branch Retinal Vein Occlusion

I.U. Scott; V. Cruz–Villegas; H.W. Flynn Jr; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1922. doi:

ARVO Annual Meeting Abstract May 2004

Local anesthesia with intravenous sedation versus general anesthesia for surgical repair of open globe injuries.

I. Voo; I.U. Scott; H.W. Flynn; Jr; J.R. Diniz

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2074. doi:

ARVO Annual Meeting Abstract May 2004

Sympathetic Ophthalmia Clinical Features and Visual Outcome

R.S. Wirthlin; J.L. Davis; H.W. Flynn; I.U. Scott; S.R. Dubovy

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2697. doi:

ARVO Annual Meeting Abstract May 2004

Intravitreal triamcinolone for the treatment of macular edema from central retinal vein occlusion

J.E. Lee; E.C. Mavrofrides; W.E. Smiddy; I.U. Scott; P.J. Rosenfeld; H.W. Flynn Jr; T.G. Murray; A.M. Berrocal; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5238. doi:

1 2

Next 20 Results »

Advertisement